Product image of Metoxaleno S.A.L.F. (Methoxsalen) supplied by GNH India

Metoxaleno S.A.L.F.

Active Ingredient:
Methoxsalen
Origin:
EU

Metoxaleno S.A.L.F. (Methoxsalen)

Methoxsalen, the active ingredient in Metoxaleno S.A.L.F., is a psoralen presented as an unspecified strength and dosage form for extracorporeal use. It is employed in photochemotherapy to treat psoriasis and vitiligo, typically in combination with UVA radiation under medical supervision by dermatology specialists.

GNH India supplies Metoxaleno S.A.L.F. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance. Our distribution network ensures timely delivery across Europe, Asia and the Americas.

Manufacturer / TM Owner

S.A.L.F. Spa Laboratorio Farmacologico

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Methoxsalen is a psoralen used in PUVA phototherapy for several dermatologic conditions.

  • Psoriasis: reduces hyperproliferative skin plaques when combined with UVA exposure.
  • Vitiligo: promotes repigmentation of depigmented areas under UVA treatment.
  • Lichen planus: may improve inflammatory lesions when administered with UVA as part of PUVA protocol.

How It Works

  • Methoxsalen intercalates between DNA base pairs and, after activation by UVA light, forms covalent cross‑links with pyrimidine residues. These cross‑links inhibit DNA synthesis and cell division, leading to reduced keratinocyte proliferation and modulation of immune responses in the skin. The photochemical reaction also induces melanocyte activation, contributing to repigmentation in vitiligo. The effect is localized to treated skin areas, minimizing systemic toxicity.

Side Effects

Methoxsalen may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Nausea: mild gastrointestinal upset after oral administration.
  • Headache: transient cranial discomfort.
  • Erythema: mild skin redness at treated sites.
  • Hyperpigmentation: increased skin coloration in exposed areas.
  • Pruritus: itching of the skin.
  • Phototoxicity: heightened skin sensitivity to light.

Serious or Rare Side Effects

  • Severe phototoxic burns: blistering and ulceration after UVA exposure.
  • Hepatotoxicity: abnormal liver enzymes indicating liver injury.
  • Aplastic anemia: rare bone‑marrow suppression.
  • Severe nausea and vomiting: persistent gastrointestinal distress.
  • Allergic reactions: rash, angioedema, or anaphylaxis.

Precautions & Warnings

When using Methoxsalen, several safety measures should be observed to minimize risks.

  • Liver function assessment: evaluate hepatic enzymes before initiating therapy.
  • Skin type evaluation: determine phototype to adjust UVA dose.
  • Sun exposure avoidance: limit natural sunlight during treatment.
  • Blood count monitoring: check complete blood count periodically.
  • Pregnancy contraindication: avoid use in pregnant patients due to unknown fetal risk.
  • Store at ambient temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Methoxsalen can interact with other medications, requiring careful management.

Major Interactions (Avoid)

  • Oral retinoids: combined use markedly increases skin toxicity.
  • Tetracycline antibiotics: may enhance phototoxic reactions.
  • Warfarin: Methoxsalen can potentiate anticoagulant effect, raising bleeding risk.

Moderate Interactions (Monitor Closely)

  • Oral contraceptives: may reduce efficacy of hormonal contraception.
  • Azole antifungals: can increase Methoxsalen plasma levels.
  • Diuretics (thiazides): may augment photosensitivity.
  • NSAIDs: monitor for increased gastrointestinal irritation.

Frequently Asked Questions

Metoxaleno S.A.L.F. contains methoxsalen, which is used in PUVA phototherapy to treat moderate to severe plaque psoriasis, vitiligo, and certain inflammatory skin disorders such as lichen planus. The drug is applied in combination with controlled UVA exposure to achieve therapeutic effects.

Methoxsalen intercalates into DNA and, when activated by UVA light, creates covalent bonds with pyrimidine bases. This cross‑linking blocks DNA replication and cell division, reducing excessive skin cell growth in psoriasis and stimulating melanocyte activity for repigmentation in vitiligo.

The dosage of Metoxaleno S.A.L.F. is determined individually by the prescribing clinician based on the patient’s condition, skin type, and treatment protocol. Dosing regimens are tailored during PUVA therapy and should follow the prescriber’s instructions.

Methoxsalen is classified as contraindicated in pregnancy because its effects on the developing fetus are unknown. Women who are pregnant, planning to become pregnant, or breastfeeding should avoid the product and discuss alternative therapies with their healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Methoxsalen is the most widely used psoralen for PUVA therapy, offering a well‑characterized safety profile and predictable photochemical activity. Compared with newer biologic agents, it requires UVA exposure but is less costly and can be effective for patients who do not respond to systemic biologics.

Store Metoxaleno S.A.L.F. at ambient temperature, preferably below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and excessive heat to maintain stability and potency.

Methoxsalen is administered extracorporeally, typically as an oral dose taken a few hours before a controlled UVA exposure session. The exact administration schedule is set by the treating dermatologist according to the PUVA protocol.

Serious risks include severe phototoxic burns, hepatotoxicity, and rare bone‑marrow suppression such as aplastic anemia. Patients should be monitored closely for signs of liver dysfunction, abnormal blood counts, and excessive skin reactions during treatment.

Individuals with a history of photosensitivity disorders, active liver disease, uncontrolled hypertension, or those who are pregnant or breastfeeding should avoid methoxsalen. It is also contraindicated in patients taking other strong photosensitizers without medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.